Antituberculosis drugs: ten years of research
YL Janin - Bioorganic & medicinal chemistry, 2007 - Elsevier
Tuberculosis is today amongst the worldwide health threats. As resistant strains of
Mycobacterium tuberculosis have slowly emerged, treatment failure is too often a fact …
Mycobacterium tuberculosis have slowly emerged, treatment failure is too often a fact …
Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery
MS Prasad, RP Bhole, PB Khedekar, RV Chikhale - Bioorganic Chemistry, 2021 - Elsevier
Enoyl acyl carrier protein reductase (InhA) is a key enzyme involved in fatty acid synthesis
mainly mycolic acid biosynthesis that is a part of NADH dependent acyl carrier protein …
mainly mycolic acid biosynthesis that is a part of NADH dependent acyl carrier protein …
Molecular descriptors and in silico studies of 4-((5-(decylthio)-4-methyl-4n-1, 2, 4-triazol-3-yl) methyl) morpholine as a potential drug for the treatment of fungal …
O Myroslava, A Poustforoosh, B Inna… - … Biology and Chemistry, 2024 - Elsevier
The article explores the polypharmacological profiling of 4-((5-(decylthio)-4-methyl-4H-1, 2,
4-triazole-3-yl) methyl) morpholine as a potential antimicrobial agent. The study utilized …
4-triazole-3-yl) methyl) morpholine as a potential antimicrobial agent. The study utilized …
Palladium-Catalyzed Ortho-Arylation of O-Phenylcarbamates with Simple Arenes and Sodium Persulfate
By palladium catalysis, the C− H bond functionalization of O-phenylcarbamates with simple
arenes has been achieved using sodium persulfate (Na2S2O8), an inexpensive, easy-to …
arenes has been achieved using sodium persulfate (Na2S2O8), an inexpensive, easy-to …
Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis
SL Kinnings, N Liu, N Buchmeier… - PLoS computational …, 2009 - journals.plos.org
The rise of multi-drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis
around the world, including in industrialized nations, poses a great threat to human health …
around the world, including in industrialized nations, poses a great threat to human health …
A machine learning-based method to improve docking scoring functions and its application to drug repurposing
SL Kinnings, N Liu, PJ Tonge… - Journal of chemical …, 2011 - ACS Publications
Docking scoring functions are notoriously weak predictors of binding affinity. They typically
assign a common set of weights to the individual energy terms that contribute to the overall …
assign a common set of weights to the individual energy terms that contribute to the overall …
Recent advancements in the development of anti-tuberculosis drugs
S Chetty, M Ramesh, A Singh-Pillay… - Bioorganic & medicinal …, 2017 - Elsevier
Modern chemotherapy has significantly improved patient outcomes against drug-sensitive
tuberculosis. However, the rapid emergence of drug-resistant tuberculosis, together with the …
tuberculosis. However, the rapid emergence of drug-resistant tuberculosis, together with the …
Drug discovery in tuberculosis. New drug targets and antimycobacterial agents
A Campaniço, R Moreira, F Lopes - European journal of medicinal …, 2018 - Elsevier
Tuberculosis (TB) remains a major health problem worldwide. The infectious agent,
Mycobacterium tuberculosis, has a unique ability to survive within the host, alternating …
Mycobacterium tuberculosis, has a unique ability to survive within the host, alternating …
Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway
H Lu, PJ Tonge - Accounts of chemical research, 2008 - ACS Publications
The modern age of drug discovery, which had been slowly gathering momentum during the
early part of the twentieth century, exploded into life in the 1940s with the isolation of …
early part of the twentieth century, exploded into life in the 1940s with the isolation of …
A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis
SR Luckner, N Liu, CW Am Ende, PJ Tonge… - Journal of Biological …, 2010 - ASBMB
InhA, the enoyl-ACP reductase in Mycobacterium tuberculosis is an attractive target for the
development of novel drugs against tuberculosis, a disease that kills more than two million …
development of novel drugs against tuberculosis, a disease that kills more than two million …